The role of biomarkers in dilated cardiomyopathy: Assessment of clinical severity and reverse remodeling
- PMID: 28989069
- DOI: 10.1016/j.repc.2017.02.015
The role of biomarkers in dilated cardiomyopathy: Assessment of clinical severity and reverse remodeling
Abstract
Introduction: Biomarkers in dilated cardiomyopathy (DCM) reflect various pathobiological processes, including neurohormonal activation, oxidative stress, matrix remodeling, myocyte injury and myocyte stretch. We assessed the role of biomarkers in clinical and echocardiographic parameters and in left ventricular (LV) reverse remodeling (LVRR).
Methods: In this prospective study of 50 DCM patients (28 men, aged 59±10 years) with LV ejection fraction (LVEF) <40%, LVRR was defined as an increase of >10 U in LVEF after optimal medical therapy.
Results: Baseline LVEF was 25.4±9.8% and LV end-diastolic diameter (LVEDD)/body surface area (BSA) was 34.2±4.5 mm/m2. LVRR occurred in 34% of patients within 17.6±15.6 months. No correlation was found between B-type natriuretic peptide (BNP), 25-hydroxyvitamin D (25(OH)D), CA-125, high-sensitivity C-reactive protein (hs-CRP), lipoprotein(a) [Lp(a)], noradrenaline, adrenaline, renin or aldosterone and LVRR. Patients in NYHA class III or IV, with pulmonary congestion or ankle edema, had higher CA-125, cystatin C, BNP and hs-CRP levels (p<0.05). CA-125 was correlated with BNP (r=0.61), hs-CRP (r=0.56) and uric acid (r=0.52) (all p=0.01). BNP correlated directly with LVEDD (r=0.49), LV volumes (r=0.51), pulmonary artery systolic pressure (PASP) (r=0.43) and E/e' (r=0.31), and was inversely correlated with LVEF (r=-0.50) and e' velocity (r=-0.32) (p<0.05). CA-125 was positively correlated with left atrial volume/BSA (r=0.46), E/A ratio (r=0.60) and PASP (r=0.49) (p<0.05).
Conclusions: No correlation was found between biomarkers and LVRR, but CA-125, BNP and hs-CRP were predictors of clinical severity and congestion. BNP correlated with parameters of systolic and diastolic dysfunction, while CA-125 correlated with measures of diastolic dysfunction.
Keywords: Biomarcadores; Biomarkers; Dilated cardiomyopathy; Miocardiopatia dilatada; Remodelagem reversa; Reverse remodeling.
Copyright © 2017 Sociedade Portuguesa de Cardiologia. Publicado por Elsevier España, S.L.U. All rights reserved.
Comment in
-
Cardiac biomarkers: on the track of reverse remodeling?Rev Port Cardiol. 2017 Oct;36(10):717-719. doi: 10.1016/j.repc.2017.09.003. Epub 2017 Oct 16. Rev Port Cardiol. 2017. PMID: 29042124 English, Portuguese. No abstract available.
Similar articles
-
Left ventricular reverse remodeling in dilated cardiomyopathy- maintained subclinical myocardial systolic and diastolic dysfunction.Int J Cardiovasc Imaging. 2017 May;33(5):605-613. doi: 10.1007/s10554-016-1042-6. Epub 2016 Dec 24. Int J Cardiovasc Imaging. 2017. PMID: 28013418
-
Novel predictors of left ventricular reverse remodeling in individuals with recent-onset dilated cardiomyopathy.J Am Coll Cardiol. 2013 Jan 8;61(1):54-63. doi: 10.1016/j.jacc.2012.07.072. J Am Coll Cardiol. 2013. PMID: 23287372
-
Prevalence, predictors and prognosis of ventricular reverse remodeling in idiopathic dilated cardiomyopathy.Rev Port Cardiol. 2016 May;35(5):253-60. doi: 10.1016/j.repc.2015.11.014. Epub 2016 Apr 23. Rev Port Cardiol. 2016. PMID: 27118094 English, Portuguese.
-
Left Ventricular Reverse Remodeling in Recent Onset Idiopathic Dilated Cardiomyopathy Using Contemporary Echo Techniques.Isr Med Assoc J. 2018 Dec;20(12):749-753. Isr Med Assoc J. 2018. PMID: 30550004
-
The impact of echocardiographic indexation to evaluate cardiac reverse remodeling throughout pregnancy and postpartum.Rev Port Cardiol. 2024 Mar;43(3):107-127. doi: 10.1016/j.repc.2023.04.014. Epub 2023 Jul 24. Rev Port Cardiol. 2024. PMID: 37495102 English, Portuguese.
Cited by
-
Effect of C reactive protein on the sodium-calcium exchanger 1 in cardiomyocytes.Exp Ther Med. 2021 Aug;22(2):815. doi: 10.3892/etm.2021.10247. Epub 2021 May 28. Exp Ther Med. 2021. PMID: 34131438 Free PMC article.
-
Use of 3D Printing Techniques to Fabricate Implantable Microelectrodes for Electrochemical Detection of Biomarkers in the Early Diagnosis of Cardiovascular and Neurodegenerative Diseases.ACS Meas Sci Au. 2023 Sep 20;3(5):315-336. doi: 10.1021/acsmeasuresciau.3c00028. eCollection 2023 Oct 18. ACS Meas Sci Au. 2023. PMID: 37868357 Free PMC article. Review.
-
CA125 as a Potential Biomarker in Non-Malignant Serous Effusions: Diagnostic and Prognostic Considerations.J Clin Med. 2025 Jun 11;14(12):4152. doi: 10.3390/jcm14124152. J Clin Med. 2025. PMID: 40565905 Free PMC article. Review.
-
CA125 as a Marker of Heart Failure in the Older Women: Population-Based Analysis.J Clin Med. 2019 May 3;8(5):607. doi: 10.3390/jcm8050607. J Clin Med. 2019. PMID: 31058877 Free PMC article.
-
BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine.Int J Mol Sci. 2019 Apr 12;20(8):1820. doi: 10.3390/ijms20081820. Int J Mol Sci. 2019. PMID: 31013779 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous